<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 45-year-old woman, who had received a single-chamber implantable cardioverter defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) due to <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> 5 years ago, was admitted for catheter ablation of incessant right ventricular outflow tract bigeminy </plain></SENT>
<SENT sid="1" pm="."><plain>After successful ablation recurrent <z:hpo ids='HP_0001664'>torsades de pointes</z:hpo> associated with a prolonged corrected QT (QTc) interval were initiated by polymorphic premature ventricular complexes </plain></SENT>
<SENT sid="2" pm="."><plain>Genetic testing revealed a heterozygous missense mutation in the SCN5A-gene (p.Arg190Gln, Exon 5), consistent with <z:hpo ids='HP_0001657'>long QT-syndrome</z:hpo> 3 </plain></SENT>
<SENT sid="3" pm="."><plain>DDDR pacing following implantation of an atrial lead prevented further ventricular tachyarrhythmias </plain></SENT>
</text></document>